Cleaning & Disinfection in Biopharma: Cutting Contamination Risk

Webinar Date: June 25, 2026
Time: 10:00 AM EDT
Duration: 1
  • <<
  • >>

As biopharmaceutical processes become more biologically complex and operationally interconnected, the impact of contamination events continues to grow. Cell and gene therapies, multiproduct facilities, single‑use systems and accelerated timelines have raised the stakes, and regulators now expect cleaning and disinfection programs to be scientifically justified and fully embedded within a robust Contamination Control Strategy (CCS).

This webinar examines how cleaning and disinfection function as critical control measures in modern biopharma manufacturing. We will explore common risk points from upstream through fill‑finish, including complex product residues, manual environmental cleaning, residue control, large cleanroom challenges and critical interfaces in single‑use and closed systems.

Aligned with the expectations outlined in EU GMP Annex 1, the session will highlight what inspectors are increasingly focused on and how a data‑led, risk‑based approach helps manufacturers strengthen contamination control while protecting product quality, supply continuity and long‑term regulatory confidence.

In this webinar you'll learn:

  • Apply a risk-based approach to cleaning and disinfection across upstream, downstream, and fill-finish operations to reduce contamination impact in increasingly complex biopharma processes.
  • Identify and control high-risk cleaning challenges, including complex product residues, limited equipment visibility, materials, and long-term asset performance.
  • Manage cleaning and disinfectant residues effectively to support compliance while protecting equipment, materials, and long-term asset performance.
  • Reduce variability in manual environmental cleaning by strengthening procedures, oversight, and data-driven controls within your contamination control strategy.
  • Align cleaning and disinfection programs with Annex 1 expectations, focusing on what inspectors are emphasizing and CCS integration supports sustained regulatory confidence.

Who should attend: 

  • Biopharmaceutical Manufacturing & Process Operations
  • Contamination Control & Environmental Monitoring
  • Quality Assurance & Compliance (GMP / Annex 1)
  • Cleaning Validation & Technical Services

Register Now

  • Please complete the following information to register for this webinar. If you already have an account, and the information will be filled out for you.
  • Please enter your mailing address.

  • The webinar sponsors and American Pharmaceutical Review may use the information you have provided to contact you about this webinar and other related topics. For more information please refer to our privacy policy.
Global Technical Consulting Manager
Ecolab Life Sciences
Global Technical Consultant Strategic Director
Ecolab Life Sciences
Image Mike Auerbach
Editor-in-Chief
American Pharmaceutical Review